Abstract
Introduction: We utilized data from the Third China National Stroke Registry to investigate the prevalence of atrial cardiopathy markers in patients with embolic stroke of undetermined source (ESUS) and to assess their association with death and stroke recurrence. Methods: In China, patients experiencing transient ischemic attack or ischemic stroke were recruited consecutively by the Third China National Stroke Registry. We compared atrial cardiopathy markers, such as left atrial (LA) enlargement, increased P-wave terminal force in lead V1 (PTFV1), premature atrial contractions, paroxysmal supraventricular tachycardia, advanced interatrial block, prolonged PR interval, prolonged P-wave dispersion, and prolonged P-wave duration between ESUS patients and those with small vessel disease and large artery atherosclerosis strokes. The association between these markers and the recurrence of stroke as well as mortality risk in ESUS patients was evaluated using Cox regression analysis. Results: Of 8,528 ischemic stroke patients who underwent a standard diagnostic workup, 2,415 were identified as having ESUS. Multivariable analysis revealed a significant association between elevated PTFV1 and an increased risk of stroke recurrence (HR: 2.50; 95% CI: 1.53–4.09; p < 0.01) as well as mortality (HR: 3.76; 95% CI: 1.58–8.91; p < 0.01) at 1 year in patients with ESUS. Furthermore, we observed that moderate-severe LA enlargement slightly increased the risk of stroke recurrence in patients with ESUS (HR: 1.95; 95% CI: 0.90–4.26; p = 0.09). Both LA diameter (HR: 1.03; 95% CI: 1.00–1.06; p = 0.03) and the top quartile of the LA diameter index (HR: 1.56; 95% CI: 1.03–2.40; p = 0.04) were associated with stroke recurrence in patients with ESUS. Conclusions: PTFV1 was independently associated with an elevated risk of stroke recurrence and mortality in ESUS patients. Additionally, a trend toward a correlation between LA enlargement and high stroke recurrence risk after ESUS was observed.
Journal Section:
Original Paper
References
1.
Hart
RG
, Diener
HC
, Coutts
SB
, Easton
JD
, Granger
CB
, O'Donnell
MJ
et al. Embolic strokes of undetermined source: the case for a new clinical construct
. Lancet Neurol
. 2014
;13
(4
):429
–38
.2.
Yang
X
, Jing
J
, Meng
X
, Li
Z
, Pan
Y
, Jiang
Y
et al. Characteristics and prognosis of patients with embolic stroke of undetermined source in China
. Int J Stroke
. 2022
;17
(5
):526
–35
.3.
Kamel
H
, Okin
PM
, Longstreth
WT
Jr, Elkind
MS
, Soliman
EZ
. Atrial cardiopathy: a broadened concept of left atrial thromboembolism beyond atrial fibrillation
. Future Cardiol
. 2015
;11
(3
):323
–31
.4.
Edwards
JD
, Healey
JS
, Fang
J
, Yip
K
, Gladstone
DJ
. Atrial cardiopathy in the absence of atrial fibrillation increases risk of ischemic stroke, incident atrial fibrillation, and mortality and improves stroke risk prediction
. J Am Heart Assoc
. 2020
;9
(11
):e013227
.5.
He
J
, Tse
G
, Korantzopoulos
P
, Letsas
KP
, Ali-Hasan-Al-Saegh
S
, Kamel
H
et al. P-wave indices and risk of ischemic stroke: a systematic review and meta-analysis
. Stroke
. 2017
;48
(8
):2066
–72
.6.
Kamel
H
, Elkind
MS
, Bhave
PD
, Navi
BB
, Okin
PM
, Iadecola
C
et al. Paroxysmal supraventricular tachycardia and the risk of ischemic stroke
. Stroke
. 2013
;44
(6
):1550
–4
.7.
O'Neal
WT
, Kamel
H
, Zhang
ZM
, Chen
LY
, Alonso
A
, Soliman
EZ
. Advanced interatrial block and ischemic stroke: the atherosclerosis risk in communities study
. Neurology
. 2016
;87
(4
):352
–6
.8.
Wang
Y
, Jing
J
, Meng
X
, Pan
Y
, Wang
Y
, Zhao
X
et al. The Third China National Stroke Registry (CNSR-III) for patients with acute ischaemic stroke or transient ischaemic attack: design, rationale and baseline patient characteristics
. Stroke Vasc Neurol
. 2019
;4
(3
):158
–64
.9.
Wu
Y
, Yang
X
, Jing
J
, Meng
X
, Li
Z
, Pan
Y
et al. Prognostic significance of atrial cardiopathy in patients with acute ischemic stroke
. Eur Stroke J
. 2023
;8
(1
):183
–90
.10.
Jalini
S
, Rajalingam
R
, Nisenbaum
R
, Javier
AD
, Woo
A
, Pikula
A
. Atrial cardiopathy in patients with embolic strokes of unknown source and other stroke etiologies
. Neurology
. 2019
;92
(4
):e288
–94
.11.
Montalvo
M
, Tadi
P
, Merkler
A
, Gialdini
G
, Martin-Schild
S
, Navalkele
D
et al. PR interval prolongation and cryptogenic stroke: a multicenter retrospective study
. J Stroke Cerebrovasc Dis
. 2017
;26
(10
):2416
–20
.12.
Acampa
M
, Lazzerini
PE
, Guideri
F
, Tassi
R
, Lo Monaco
A
, Martini
G
. Inflammation and atrial electrical remodelling in patients with embolic strokes of undetermined source
. Heart Lung Circ
. 2019
;28
(6
):917
–22
.13.
Lang
RM
, Bierig
M
, Devereux
RB
, Flachskampf
FA
, Foster
E
, Pellikka
PA
et al. Recommendations for chamber quantification
. Eur J Echocardiogr
. 2006
;7
(2
):79
–108
.14.
Adams
HP
Jr, Bendixen
BH
, Kappelle
LJ
, Biller
J
, Love
BB
, Gordon
DL
et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment
. Stroke
. 1993
;24
(1
):35
–41
.15.
Jiang
X
, Quan
X
, Yang
J
, Zhou
X
, Hu
A
, Zhang
Y
. Electrocardiographic criteria for the diagnosis of abnormal hypertensive cardiac phenotypes
. J Clin Hypertens
. 2019
;21
(3
):372
–8
.16.
Kamel
H
, Bartz
TM
, Elkind
MSV
, Okin
PM
, Thacker
EL
, Patton
KK
et al. Atrial cardiopathy and the risk of ischemic stroke in the CHS (cardiovascular Health study)
. Stroke
. 2018
;49
(4
):980
–6
.17.
Tiffany Win
T
, Ambale Venkatesh
B
, Volpe
GJ
, Mewton
N
, Rizzi
P
, Sharma
RK
et al. Associations of electrocardiographic P-wave characteristics with left atrial function, and diffuse left ventricular fibrosis defined by cardiac magnetic resonance: the PRIMERI Study
. Heart Rhythm
. 2015
;12
(1
):155
–62
.18.
Kamel
H
, Bartz
TM
, Longstreth
WT
Jr, Okin
PM
, Thacker
EL
, Patton
KK
et al. Association between left atrial abnormality on ECG and vascular brain injury on MRI in the Cardiovascular Health Study
. Stroke
. 2015
;46
(3
):711
–6
.19.
Eranti
A
, Aro
AL
, Kerola
T
, Anttonen
O
, Rissanen
HA
, Tikkanen
JT
et al. Prevalence and prognostic significance of abnormal P terminal force in lead V1 of the ECG in the general population
. Circ Arrhythm Electrophysiol
. 2014
;7
(6
):1116
–21
.20.
Tanoue
MT
, Kjeldsen
SE
, Devereux
RB
, Okin
PM
. Relationship between abnormal P-wave terminal force in lead V(1) and left ventricular diastolic dysfunction in hypertensive patients: the LIFE study
. Blood Press
. 2017
;26
(2
):94
–101
.21.
Froehlich
L
, Meyre
P
, Aeschbacher
S
, Blum
S
, Djokic
D
, Kuehne
M
et al. Left atrial dimension and cardiovascular outcomes in patients with and without atrial fibrillation: a systematic review and meta-analysis
. Heart
. 2019
;105
(24
):1884
–91
.22.
Yaghi
S
, Moon
YP
, Mora-McLaughlin
C
, Willey
JZ
, Cheung
K
, Di Tullio
MR
et al. Left atrial enlargement and stroke recurrence: the northern manhattan stroke study
. Stroke
. 2015
;46
(6
):1488
–93
.23.
Silva
AR
, Pires
C
, Meira-Carvalho
F
, Santos
M
, Antunes
NP
, Alves
JN
et al. Atrial cardiopathy predicts detection of atrial fibrillation in embolic stroke of undetermined source: real-life data
. Neurol Sci
. 2022
;43
(4
):2383
–6
.24.
D'Alessandro
E
, Winters
J
, van Nieuwenhoven
FA
, Schotten
U
, Verheule
S
. The complex relation between atrial cardiomyopathy and thrombogenesis
. Cells
. 2022
;11
(19
):2963
.25.
Yaghi
S
, Bartz
TM
, Kronmal
R
, Kamel
H
, Gottdiener
J
, Longstreth
WT
Jret al. Left atrial diameter and vascular brain injury on MRI: the Cardiovascular Health Study
. Neurology
. 2018
;91
(13
):e1237
–44
.26.
Acampa
M
, Guideri
F
, Tassi
R
, Dello Buono
D
, Celli
L
, di Toro Mammarella
L
et al. P wave dispersion in cryptogenic stroke: a risk factor for cardioembolism
. Int J Cardiol
. 2015
;190
:202
–4
.27.
Larsen
BS
, Kumarathurai
P
, Falkenberg
J
, Nielsen
OW
, Sajadieh
A
. Excessive atrial ectopy and short atrial runs increase the risk of stroke beyond incident atrial fibrillation
. J Am Coll Cardiol
. 2015
;66
(3
):232
–41
.28.
Kamel
H
, Longstreth
WT
Jr, Tirschwell
DL
, Kronmal
RA
, Broderick
JP
, Palesch
YY
et al. The AtRial Cardiopathy and Antithrombotic Drugs in prevention after cryptogenic stroke randomized trial: rationale and methods
. Int J Stroke
. 2019
;14
(2
):207
–14
.29.
Geisler
T
, Poli
S
, Meisner
C
, Schreieck
J
, Zuern
CS
, Nägele
T
et al. Apixaban for treatment of embolic stroke of undetermined source (ATTICUS randomized trial): rationale and study design
. Int J Stroke
. 2017
;12
(9
):985
–90
.30.
Schweizer
J
, Arnold
M
, König
IR
, Bicvic
A
, Westphal
LP
, Schütz
V
et al. Measurement of midregional pro-atrial natriuretic peptide to discover atrial fibrillation in patients with ischemic stroke
. J Am Coll Cardiol
. 2022
;79
(14
):1369
–81
.31.
Tan
BYQ
, Ho
JSY
, Sia
CH
, Boi
Y
, Foo
ASM
, Dalakoti
M
et al. Left atrial volume index predicts new-onset atrial fibrillation and stroke recurrence in patients with embolic stroke of undetermined source
. Cerebrovasc Dis
. 2020
;49
(3
):285
–91
.© 2023 S. Karger AG, Basel
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
2023
You do not currently have access to this content.
